Literature DB >> 1836687

The impact of three-monthly age-targetted chemotherapy on Ascaris lumbricoides infection.

.   

Abstract

The impact of 3 chemotherapeutic regimens at 3-monthly intervals against Ascaris lumbricoides infection, targetted at under 15 years old children with and without initial mass chemotherapy, and at 2-12 years old children, was studied in three Myanmar [Burmese] rural communities over a period of 2 years. Computation was made of prevalence and intensity (worm burden) of Ascaris infection, and other parameters for estimation of basic reproductive rate (R0) of the parasite and of the proportion of target age group to be treated 3-monthly (g) by employing the mathematical model for targetted chemotherapy. The 3 treatment regimens were almost equally effective in reducing prevalence and intensity in both the targetted and non-targetted age groups. Ascaris transmission in each of the 3 communities was interrupted, as indicated by the values of mean worm burden per person. The findings are compared with those of other similar studies and the reasons for the impact are discussed. The possible impact in similar endemic areas of applying the mathematical model predictions for age-targetted chemotherapy in controlling ascariasis is also discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836687     DOI: 10.1016/0035-9203(91)90241-p

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  7 in total

1.  Genes on chromosomes 1 and 13 have significant effects on Ascaris infection.

Authors:  Sarah Williams-Blangero; John L VandeBerg; Janardan Subedi; Mary Jo Aivaliotis; Dev Raj Rai; Ram Prasad Upadhayay; Bharat Jha; John Blangero
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

2.  Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections.

Authors:  Ana Lucia Moncayo; Maritza Vaca; Leila Amorim; Alejandro Rodriguez; Silvia Erazo; Gisela Oviedo; Isabel Quinzo; Margarita Padilla; Martha Chico; Raquel Lovato; Eduardo Gomez; Mauricio L Barreto; Philip J Cooper
Journal:  PLoS Negl Trop Dis       Date:  2008-09-10

3.  Patterns of soil-transmitted helminth infection and impact of four-monthly albendazole treatments in preschool children from semi-urban communities in Nigeria: a double-blind placebo-controlled randomised trial.

Authors:  Patrick Kirwan; Samuel O Asaolu; Síle F Molloy; Titilayo C Abiona; Andrew L Jackson; Celia V Holland
Journal:  BMC Infect Dis       Date:  2009-02-19       Impact factor: 3.090

4.  Anthelmintic drugs for treating ascariasis.

Authors:  Lucieni O Conterno; Marilia D Turchi; Ione Corrêa; Ricardo Augusto Monteiro de Barros Almeida
Journal:  Cochrane Database Syst Rev       Date:  2020-04-14

Review 5.  The Human Hookworm Vaccine.

Authors:  Peter J Hotez; David Diemert; Kristina M Bacon; Coreen Beaumier; Jeffrey M Bethony; Maria Elena Bottazzi; Simon Brooker; Artur Roberto Couto; Marcos da Silva Freire; Akira Homma; Bruce Y Lee; Alex Loukas; Marva Loblack; Carlos Medicis Morel; Rodrigo Correa Oliveira; Philip K Russell
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

Review 6.  The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths.

Authors:  Roy Anderson; James Truscott; T Deirdre Hollingsworth
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-05-12       Impact factor: 6.237

7.  Therapeutic efficacy of different brands of albendazole against soil transmitted helminths among students of Mendera Elementary School, Jimma, Southwest Ethiopia.

Authors:  Ephrem Tefera; Tariku Belay; Seleshi Kebede Mekonnen; Ahmed Zeynudin; Tefera Belachew
Journal:  Pan Afr Med J       Date:  2015-11-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.